Anne M. Hause

1.8k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Anne M. Hause is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Anne M. Hause has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 18 papers in Health and 10 papers in Epidemiology. Recurrent topics in Anne M. Hause's work include Vaccine Coverage and Hesitancy (18 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral Infections and Immunology Research (8 papers). Anne M. Hause is often cited by papers focused on Vaccine Coverage and Hesitancy (18 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral Infections and Immunology Research (8 papers). Anne M. Hause collaborates with scholars based in United States, Chile and Puerto Rico. Anne M. Hause's co-authors include David K. Shay, Paige Marquez, Julianne Gee, Tom T. Shimabukuro, Tanya R. Myers, John R. Su, James Baggs, Deborah Thompson, Bicheng Zhang and Kristy O. Murray and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Anne M. Hause

34 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

2022 116 citations Hannah G. Rosenblum, Julianne Gee et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne M. Hause United States	21	768	363	275	187	159	34	1.1k
Kristin Goddard United States	16	563 0.7×	314 0.9×	354 1.3×	184 1.0×	141 0.9×	50	1.2k
Karina A. Top Canada	16	352 0.5×	260 0.7×	241 0.9×	220 1.2×	136 0.9×	76	855
Paige Marquez United States	23	1.1k 1.4×	630 1.7×	298 1.1×	431 2.3×	76 0.5×	58	1.8k
Olivier Marion France	20	1.2k 1.5×	182 0.5×	241 0.9×	86 0.5×	40 0.3×	52	1.7k
Srinivas Rao Valluri United States	15	1.0k 1.3×	454 1.3×	137 0.5×	79 0.4×	60 0.4×	44	1.6k
Rulin C. Hechter United States	18	425 0.6×	211 0.6×	718 2.6×	93 0.5×	111 0.7×	82	1.3k
Ned Lewis United States	23	780 1.0×	464 1.3×	1.0k 3.7×	249 1.3×	66 0.4×	55	2.0k
Amadea Britton United States	15	968 1.3×	444 1.2×	569 2.1×	49 0.3×	41 0.3×	23	1.5k
Glen R. Abedi United States	16	559 0.7×	122 0.3×	815 3.0×	74 0.4×	73 0.5×	23	1.3k
Bruno Lewin United States	16	672 0.9×	233 0.6×	244 0.9×	190 1.0×	24 0.2×	67	1.2k

Countries citing papers authored by Anne M. Hause

Since Specialization

Citations

This map shows the geographic impact of Anne M. Hause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Hause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Hause more than expected).

Fields of papers citing papers by Anne M. Hause

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Hause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Hause. The network helps show where Anne M. Hause may publish in the future.

Co-authorship network of co-authors of Anne M. Hause

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Hause. A scholar is included among the top collaborators of Anne M. Hause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Hause. Anne M. Hause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hause, Anne M., Paige Marquez, Bicheng Zhang, et al.. (2023). Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023. MMWR Morbidity and Mortality Weekly Report. 72(2). 39–43. 23 indexed citations

Myers, Tanya R., Paige Marquez, Julianne Gee, et al.. (2023). The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response. Vaccine. 41(7). 1310–1318. 15 indexed citations

Hause, Anne M., Paige Marquez, Bicheng Zhang, et al.. (2023). Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023. MMWR Morbidity and Mortality Weekly Report. 72(23). 621–626. 4 indexed citations

Tompkins, Lindsay K., James Baggs, Tanya R. Myers, et al.. (2022). Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults. Vaccine. 40(52). 7653–7659. 2 indexed citations

Rosenblum, Hannah G., Julianne Gee, Ruiling Liu, et al.. (2022). Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. The Lancet Infectious Diseases. 22(6). 802–812. 116 indexed citations breakdown →

Kenigsberg, Tat’Yana A., Anne M. Hause, Michael M. McNeil, et al.. (2022). Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink. Vaccine. 40(22). 3064–3071. 6 indexed citations

Hause, Anne M., Paige Marquez, Bicheng Zhang, et al.. (2022). Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022. MMWR Morbidity and Mortality Weekly Report. 71(44). 1401–1406. 50 indexed citations

Wong, Karen K., Charles M. Heilig, Anne M. Hause, et al.. (2022). Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study. The Lancet Digital Health. 4(9). e667–e675. 38 indexed citations

Hause, Anne M., Julianne Gee, Amelia Jazwa, et al.. (2021). Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021. MMWR Morbidity and Mortality Weekly Report. 70(18). 685–688. 56 indexed citations

10.

Blau, Erin F., Kathleen P. Hartnett, Michael A. Curran, et al.. (2021). Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations — Indiana, Kentucky, and Ohio, September 2018–February 2019. MMWR Morbidity and Mortality Weekly Report. 70(42). 1472–1477. 1 indexed citations

11.

Hause, Anne M., Julianne Gee, James Baggs, et al.. (2021). COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021. MMWR Morbidity and Mortality Weekly Report. 70(31). 1053–1058. 111 indexed citations

12.

Hause, Anne M., Lakshmi Panagiotakopoulos, Eric Weintraub, et al.. (2020). Adverse Outcomes in Pregnant Women Hospitalized With Respiratory Syncytial Virus Infection: A Case Series. Clinical Infectious Diseases. 72(1). 138–140. 10 indexed citations

13.

Hause, Anne M., Vasanthi Avadhanula, Maurizio Maccato, et al.. (2019). Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women. Vaccine. 37(26). 3464–3471. 21 indexed citations

14.

Hause, Anne M., Vasanthi Avadhanula, Maurizio Maccato, et al.. (2017). A Cross-Sectional Surveillance Study of Acute Respiratory Illness (ARI) in Pregnant Women. Open Forum Infectious Diseases. 4(suppl_1). S573–S573. 1 indexed citations

15.

Hause, Anne M., David Henke, Vasanthi Avadhanula, et al.. (2017). Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. PLoS ONE. 12(4). e0175792–e0175792. 72 indexed citations

16.

Piedra, Pedro A., Anne M. Hause, & Letisha Aideyan. (2016). Respiratory Syncytial Virus (RSV): Neutralizing Antibody, a Correlate of Immune Protection. Methods in molecular biology. 1442. 77–91. 18 indexed citations

17.

Hause, Anne M., Janice Pérez‐Padilla, Kalanthe Horiuchi, et al.. (2015). Epidemiology of Dengue Among Children Aged < 18 Months—Puerto Rico, 1999–2011. American Journal of Tropical Medicine and Hygiene. 94(2). 404–408. 8 indexed citations

18.

Garcia, Melissa N., Anne M. Hause, Christopher M. Walker, et al.. (2014). Evaluation of Prolonged Fatigue Post–West Nile Virus Infection and Association of Fatigue with Elevated Antiviral and Proinflammatory Cytokines. Viral Immunology. 27(7). 327–333. 63 indexed citations

19.

Nolan, Melissa S., Anne M. Hause, & Kristy O. Murray. (2012). Findings of Long‐Term Depression up to 8 Years Post Infection From West Nile Virus. Journal of Clinical Psychology. 68(7). 801–808. 30 indexed citations

20.

Nolan, Melissa S., et al.. (2012). Prevalence of Chronic Kidney Disease and Progression of Disease Over Time among Patients Enrolled in the Houston West Nile Virus Cohort. PLoS ONE. 7(7). e40374–e40374. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact